GLP-1(7-36) amide vs Nafarelin

Head-to-head comparison of GLP-1(7-36) amide (Glucagon-like peptide-1 (7-36) amide) and Nafarelin (Nafarelin acetate) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyGLP-1(7-36) amideNafarelin
CategoryEndocrine PeptidesSexual Health
Full NameGlucagon-like peptide-1 (7-36) amideNafarelin acetate
Molecular Weight3297.7 Da1321.47 Da
Half-Life1-2 min~2-4 hours
Amino AcidsHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH210
Typical DosepM-nM physiologic range|research-dependent200 mcg intranasal twice daily
Routeendogenous secretion|SC/IV in research/clinical analog studiesIntranasal
Purity≥98%≥98%
Studies Count99220
Research StatusEndogenousClinical

GLP-1(7-36) amide Benefits

  • glucose-dependent insulin secretion
  • gastric emptying delay
  • satiety signaling

Nafarelin Benefits

  • pituitary suppression
  • cycle scheduling
  • endometriosis-related reproductive care
  • controlled hormone modulation

GLP-1(7-36) amide Dosing

physiologic secretion|research-dependent

Nafarelin Dosing

200 mcg intranasal twice daily|0.4 mg/day intranasal|protocol-based suppression cycles

GLP-1(7-36) amide Side Effects

  • nausea
  • fullness
  • reduced appetite

Nafarelin Side Effects

  • nasal irritation
  • hot flashes
  • headache

Research Overview

GLP-1(7-36) amide

One of the best-studied gut hormones, with strong evidence for incretin biology and appetite regulation. Native GLP-1 is rapidly degraded by DPP-4, which is why its biology is central to endocrine and metabolic pharmacology.

Nafarelin

Nafarelin has a long history in reproductive medicine, especially for endometriosis and cycle suppression. Studies show it down-regulates the HPG axis after an initial stimulatory flare.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

GLP-1(7-36) amide stacks with:

L-cellsinsulinsatiety

Nafarelin stacks with:

FSHhCG
gut-hormoneincretinendocrine-peptideGnRH-agonistfertilityendocrinology